SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-107104
Filing Date
2016-03-23
Accepted
2016-03-23 13:42:35
Documents
2
Period of Report
2016-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-7020_18k.htm 8-K 20081
2 EX-99.1 a16-7020_1ex99d1.htm EX-99.1 111544
  Complete submission text file 0001104659-16-107104.txt   132899
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 161523503
SIC: 2834 Pharmaceutical Preparations